Morning Session

Regulation,Outlook and Trend

Compliance, Quality and Data Integrity

Strategic Partnerships & Clinical Outsourcing

Afternoon Session

Patient Centric, Site Selection and Project Management

Innovation ,Technology and Analytics

Oncology Drug Development ,Biologics & Biosimilar

Speaker
  • Joseph Scheeren
    Senior VP,Head of Global Regulatory
    Bayer Healthcare, China
  • Stewart Geary
    Senior Vice President, Chief Medical Officer
    Corporate Medical Affairs Headquarters, Eisai, Japan
  • Yao-Chang Xu
    CEO
    Abbisko Therapeutics Co., Ltd., China
  • Joe Zhou
    CEO
    Walvax, China
  • Wu Tai Xiang
    Director
    Chinese Clinical Trials Registry, China
  • George Liu
    Vice President, Early Development
    Harbour Biomed, China
  • Patrick Kos
    VP Compliance
    Roche China
  • Nellie Chen
    Director of Clinical Operations
    ASLAN Pharmaceuticals, China
  • Dr Wang Ji Yao
    Huashan Hospital
    Huashan Hospital Shanghai Fudan University, China
  • Fred Li Yong-Guo
    Vice President, Pharmaceutical R&D
    Hua Medicine (Shanghai) Limited, China
  • James Cheong
    Senior Director of Clinical Operations
    Boehringer Ingelheim, China
  • George Guo
    GMO Country Head
    Novartis Pharmaceuticals (China) Oncology, China
  • Paul Kong
    Director of Clinical Operations
    Fibrogen, China
  • Xin Zhang
    Senior Director, Clinical Operations
    Shanghai Henlius Biotech Co Ltd, China
  • Rebecca Dai
    Head Clinical Project Management
    Bayer Pharmaceuticals, China
  • Wang Hao
    Head of Clinical Operations
    Bristol Myers Squibbs Pte Ltd, China
  • Helen Lin
    Executive Medical Director
    Amgen, China
  • Zhao Xianfeng
    Head of Clinical Research
    Abbott Nutrition R&D, China
  • Ye Hua
    SVP,Head of Clinical Development
    HUTCHISON MEDIPHARMA
  • Simon Li
    Vice President, Global Clinical Development
    LUYE PHARMA

For more information,pls contact us by 021-31602153 or Email to marketing@wbfgroup.com